Read More Pharma Industry News ALX Oncology raises $105m to advance clinical development of ALX148 ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a Series C equity… bypharmanewsdailyFebruary 14, 2020
